Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of the Safety and Efficacy of a Single Dose of SKY0402 in Subjects Undergoing Augmentation Mammoplasty
This study has been completed.
Study NCT01206608   Information provided by Pacira Pharmaceuticals, Inc

First Received on September 19, 2010.   Last Updated on November 6, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mammoplasty
Interventions listed in this trial
SKY0402 + bupivacaine HCl
Mid-dose SKY0402 + bupivacaine HCl
Additional drug interventions recognized in this trial
Bupivacaine
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Pacira Pharmaceuticals, Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services